Artificial intelligence to begin reading pet X-Rays
SAN DIEGO, Calif. - July 31, 2018 (Investorideas.com Newswire) Vetology® Innovations, LLC, an advanced technology company serving the veterinary industry, announced on Tuesday, the launch of the only artificial intelligence (AI) radiology software designed to provide veterinary professionals with a first-of-its-kind automated diagnostic resource of patient radiographs (X-Rays).
Vetology® AI, which has been in development since 2017, provides a comprehensive, rapid and affordable resource for veterinarians evaluating patient radiographs and determining necessary medical treatments.
The AI software developed by Vetology® utilizes artificial neural networks that are trained on known normal and abnormal X-Ray images. Through this specialized machine learning process, the software is able to alert a veterinarian to the presence or lack of medical abnormalities without human oversight.
"Pioneering the creation of this technology for the veterinary industry has been our goal for many years. We're incredibly proud of what we've accomplished and what it means for the future of those who are committed to delivering better patient care," said Dr. Seth Wallack, DACVR, founder of Vetology® Innovations. "Without a doubt, AI will have a dramatic and positive effect on the entire veterinary industry."
With Vetology® AI, veterinarians will be able to upload an image and receive a written analysis in less than 90 seconds, allowing for more immediate decision making and consultation with pet owners.
Key features of the Vetology® AI software include automated heart size evaluation and Vertebral Heart Score Calculations. Vetology® AI works autonomously, automatically uploading a clinic's X-Rays to the secure Vetology® cloud where the software intuitively determines the potential of cardiac problems based on heart size and the comparative size of the heart in relation to the vertebral body size of the patient.
With chest x-rays being the most common screening test to look for lung infection, cancer or heart disease, the heart evaluation technology of Vetology® AI can be a very powerful resource for veterinarians.
"The automated heart evaluation function of our AI technology is something we are excited about because without any input from a human, the software can immediately notify a veterinarian that further cardiac evaluation may be needed," said Wallack. "This technology is not even being used in human medicine yet and will continue to improve with self-teaching."
Vetology® AI includes image storage, unlimited automated heart size evaluations and automated Vertebral Heart Score calculations. Additionally, sign up is simple and can be completed online at https://ai.vetology.net/. This technology cost-effectively answers a rising unmet demand in the veterinary industry as more owner's request, and progressive veterinary hospitals deliver, an advancing level of veterinary care.
Founded in 2011 and headquartered in San Diego, California, Vetology® provides innovative and emerging technology solutions for the veterinary community. The company serves over 2,000 veterinary hospitals worldwide and offers SAAS products that facilitate the highest quality of patient care and services.
Vetology® is a registered trademark of the Veterinary Imaging Center of San Diego, Inc.
TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)
Like Tech Stocks? View our Tech Stocks Directory
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.